AI-based Predictive and Interventional System for Early Detection of Non-compliance Risks With Oral Therapies in Lymphoma Patients.

This research forms part of a continuous quality improvement initiative. It aims to assess patient compliance of oral therapies by artificial intelligence. It could overcome the limitations of current practices and enhance the responsiveness and accuracy of clinical interventions.

NCT Number	NCT07546188
Lead Sponsor	Grand Hôpital de Charleroi
Conditions	Lymphoma, Non-Hodgkin, Care Coordination
Enrollment	210 participants
Start Date	2026-02-15
Primary Completion	2027-12-31 (estimated)
Study Completion	2029-02-15 (estimated)
Updated on ClinicalTrials.gov	2026-04-22